Scholar Rock (NASDAQ:SRRK) Trading Up 7.1% – Still a Buy?

Scholar Rock Holding Corporation (NASDAQ:SRRK) traded up 7.1% during trading on Thursday . The company traded as high as $42.96 and last traded at $42.61. 1,221,099 shares changed hands during trading, an increase of 11% from the average session volume of 1,100,697 shares. The stock had previously closed at $39.79.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on SRRK shares. Citigroup boosted their target price on shares of Scholar Rock from $55.00 to $58.00 and gave the stock a “buy” rating in a research report on Wednesday, March 4th. Barclays lifted their price target on Scholar Rock from $52.00 to $53.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 3rd. Cantor Fitzgerald reissued an “overweight” rating on shares of Scholar Rock in a report on Thursday, December 11th. Raymond James Financial restated a “strong-buy” rating on shares of Scholar Rock in a research note on Tuesday, March 3rd. Finally, Piper Sandler lifted their target price on Scholar Rock from $51.00 to $58.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 4th. Four investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $54.36.

Scholar Rock Stock Up 8.4%

The company has a debt-to-equity ratio of 0.41, a current ratio of 6.95 and a quick ratio of 6.95. The stock’s fifty day simple moving average is $45.05 and its 200-day simple moving average is $39.79. The stock has a market cap of $4.96 billion, a P/E ratio of -12.53 and a beta of 0.70.

Scholar Rock (NASDAQ:SRRK) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.76) EPS for the quarter, beating the consensus estimate of ($0.86) by $0.10. During the same period in the prior year, the business earned ($0.64) EPS. On average, research analysts anticipate that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current year.

Insider Activity

In other news, insider Mo Qatanani sold 14,898 shares of the company’s stock in a transaction dated Thursday, January 22nd. The shares were sold at an average price of $46.71, for a total transaction of $695,885.58. Following the completion of the transaction, the insider owned 85,660 shares in the company, valued at approximately $4,001,178.60. This represents a 14.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Vikas Sinha sold 16,755 shares of the stock in a transaction dated Tuesday, January 13th. The stock was sold at an average price of $42.70, for a total transaction of $715,438.50. Following the completion of the sale, the chief financial officer directly owned 583,245 shares in the company, valued at approximately $24,904,561.50. This trade represents a 2.79% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 207,464 shares of company stock worth $9,157,423 over the last 90 days. Insiders own 13.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of SRRK. Moody Aldrich Partners LLC raised its holdings in shares of Scholar Rock by 53.5% during the third quarter. Moody Aldrich Partners LLC now owns 101,742 shares of the company’s stock valued at $3,789,000 after buying an additional 35,481 shares during the last quarter. Norges Bank acquired a new position in shares of Scholar Rock during the second quarter worth approximately $41,628,000. Voya Investment Management LLC grew its holdings in Scholar Rock by 18.1% in the 3rd quarter. Voya Investment Management LLC now owns 443,155 shares of the company’s stock worth $16,503,000 after buying an additional 67,839 shares in the last quarter. HighVista Strategies LLC increased its position in Scholar Rock by 90.8% in the 3rd quarter. HighVista Strategies LLC now owns 59,573 shares of the company’s stock valued at $2,218,000 after acquiring an additional 28,343 shares during the period. Finally, Nan Fung Trinity HK Ltd. acquired a new stake in Scholar Rock in the 3rd quarter valued at approximately $1,402,000. Institutional investors own 91.08% of the company’s stock.

About Scholar Rock

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).